Ophthalmic Research

The Emory Eye Center's Research División encompasses nine lab groups, a clinical trials program, and more than 50 research specialists, post-docs, and students (the "research team"), all of who are committed to identifying and pursuing science that transforms lives by translating research into new prevention and treatment for all vision disorders and diseases.

Researching the future of vision health

Dr. Machelle T. Pardue, PhD, vice chair and director of research — Machelle T. Pardue, PhD, vice chair and director of research

All of our scientists are steadfast in their commitment to translational research - an approach to scientific inquiry that identifies patient well-being as the ultimate answer to every question we ask. We are also committed to collaborative research - an approach to investigation that produces impactful results by drawing upon the diverse talents of multiple medical specialties, academic disciplines, and clinical observations.

Feola's glaucoma research earns support of VA, NIH

Grants from both the National Institutes of Health (NIH) and the Veteran’s Administration (VA) are allowing Dr. Andrew J. Feola to further explore the role that menopause and hormones play in the onset and treatment of glaucoma. read more

Investigating new approaches to ROP

The Research Division of the Department of Ophthalmology has attracted inspired funding from a broad range of public and private sources, including NIH, NEI, and ARVO.

A two-year $430K grant from the National Eye Institute will enable Department of Ophthalmology researchers Mike Iuvone, PhD and Jeffrey Boatright, PhD to conduct proof-of-concept studies for a novel treatment for retinopathy of prematurity (ROP).

The non-invasive approach is outlined in their proposal, “Atypical Opsins and the Oxygen-Induced Retinopathy (OIR) Model of Retinopathy of Prematurity” which was approved for funding in the spring os 2023. read more